| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Revenue | $661.5M | -31.9% |
| Cost of Revenue | $593.7M | -34.2% |
| Gross Profit | $67.8M | -3.1% |
| R&D Expense | $100K | +0.0% |
| SG&A Expense | $50.0M | -24.6% |
| Operating Income | $16.7M | +3807.2% |
| Pre-tax Income | $9.2M | +553.0% |
| Income Tax | $2.3M | -60.9% |
| Net Income | -$1.1M |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.0M | +2627.5% |
| Accounts Receivable | $41.9M | -31.7% |
| Inventory | $34.2M | -13.4% |
| Current Assets | $158.6M | +18.9% |
| Total Assets | $301.1M | -22.2% |
| Current Liabilities | $73.2M | -10.4% |
| Stockholders' Equity | $201.8M | -4.0% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.4M | +268.8% |
| Capital Expenditures | $2.9M | -73.0% |
| Investing Cash Flow | $80.1M | +849.1% |
| Financing Cash Flow | -$50.4M | -302.4% |
| Free Cash Flow | $21.5M | +185.6% |
| +87.1% |
| EPS (Basic) | -$0.06 | +87.2% |
| EPS (Diluted) | -$0.06 | +87.2% |